期刊文献+

急性时相反应及凝血/纤溶系统参与慢性荨麻疹发病的研究进展 被引量:5

Acute-phase Response and Coagulation/Fibrinolysis in the Pathogenesis of Chronic Urticaria
下载PDF
导出
摘要 慢性荨麻疹的病因复杂且仍然未完全清楚。已有文献报道慢性荨麻疹患者部分急性时相标记物水平升高,提示急性时相反应有可能参与了慢性荨麻疹的发病;另一方面,已证实慢性荨麻疹患者内、外凝血途径激活,多种凝血因子水平升高,并与慢性荨麻疹症状严重程度相关;在多种疾病中,急性时相反应与凝血/纤溶功能关系密切。本文就急性时相反应及凝血/纤溶系统参与慢性荨麻疹发病的周内外研究现状与进展作一综述。 The exact pathogenic meehanism of chronic urticaria(CU) is complex and unclear. It has been shown that concentrations of circulating acute-phase response biomarkers are elevated in chronic urticaria, suggesting the involvement of acute-phase response in the development of CU. Recently, it has been demonstrated that the activation of the coagulation/fibrinolysis and the increased level of coagulation factors may be correlated with the disease severity. The association of acute-phase response with coagulation/fibrinolysis has been shown in many diseases. This review summarized the recent advances and developments of chronic urticaria about acute-phase response and coagulation/fibrinolysis.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2014年第1期84-86,共3页 The Chinese Journal of Dermatovenereology
关键词 慢性荨麻疹 急性时相反应 血液凝固因子 Chronic urticaria Acute-phase response Blood coagulation factors
  • 相关文献

参考文献26

  • 1Kasperska-Zajac A. Acute-phase response in chronic urticaria[ J]. JEADV,2012,26(6 ) : 665 - 672.
  • 2Kasperska-Zajac A, Brzoza Z, Rogala B. Plasma concentration of interleukin 6 (IL- 6 ), and its relationship with circulating con- centration of dehydroepiandrosterone sulfate (DHEA-S) in patients with chronic idio- pathic urticaria [ J ]. Cytokine ,2007,39 ( 2 ) : 142 - 146.
  • 3Kasperska-Zajac A, Sztylc J, Maehura M, et al. Plasma IL-6 concentration coxTelates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria pa- tients[J]. Clinical Experimental Allergy, 2011,41 (10) :1386- 1391.
  • 4Dos Santos JC,Azor MH, Nojima VY, et al. Increased circulating pro-inflammatory cyto- kines and imbalaneed regulatory T-cell eyto- kines production in chronic idiopathic urti- caria [ J ]. International Immunopharmacolo- gy,2008,8(10) :1433 - 1440.
  • 5王颖超,史同新,李民,赵光,苏磊,王丽欣,李洋.慢性特发性荨麻疹患者血清IL-6、IL-12P70和β-内啡肽及组胺测定[J].中国麻风皮肤病杂志,2010,26(2):89-91. 被引量:6
  • 6Oishi K, Machida K. Some plasma compo- nent is essential for IL6 secretion by neutro- phils[ J]. Environ Health Prev Med, 1997,2 (2) :89 -92.
  • 7Nettis E,Dambra P,Loria MP,et al. Mast-cell phenotype in urticaria[ J]. Allergy,2001,56 (9) :915.
  • 8Lawlor F, Bird C, Camp RD, et al. Increased interleukin 6, but reduced interleukin 1, in delayed pressure urticaria [ J ]. Br J Derma- tol, 1993,128 ( 5 ) :500 - 503.
  • 9Fujii K,Konishi K,Kanno Y ,et al. Acute ur- ticaria with elevated circulating interleukin-6 is resistant to anti-histamine treatment[J]. J Dermato1,2001,28 ( 5 ) :248 - 250.
  • 10Tedeschi A, Asero R, Lorini M, et al. Plas- ma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with dis- ease severity and C-reactive protein but not with circulating histanfine-releasing factors [ J ]. Clinical Experimental Allergy, 2010, 40(6) :875 -881.

二级参考文献30

共引文献16

同被引文献44

  • 1Van Cauwenberge P, De Belder T, Sys L. A review of the second- generation antihist amine edastine for the treatment of allergic disorders [J]. Expert Opin Pharmacother, 2004, 5(8):1807-1813.
  • 2Boraschi D, Dinarello CA. IL-18 in autoimmunity: review [J]. Eur Cytokine Netw, 2006, 17(4):224-252.
  • 3Nakamura K, Okamura H, Nagata K, et al. Purification of a factor which provides a costimulatory signal for gamma interferon production [J]. Infect Immun, 1993, 61 (1):64-70.
  • 4EI-Mezayen RE, Matsumoto T. In vitro responsiveness to IL-18 in combination with IL-12 or IL-2 by PBMC from patients with bronchial asthma and atopic dermatitis [J]. Clin Immunol, 2004, 111(1):61-68.
  • 5Schmitz J, Owyang A, Oldham E, et al. IL-33,an interleukin-l-like cytokine flint signals via the IL-1 receptor-fator-related protein ST2 and induces T helper type2-associated cytokines [J]. Immunity, 2005, 23(5):479-490.
  • 6Palmer G, Gabay C. Interleukin-33 biology with potential insights into human diseases [J]. Nat Rev Rheumatol, 201, 7(6):321-329.
  • 7Geha RS, Meltzer EO. Desloratadine: A new, nonnsedatlng, oral antihistamine[J]. J Allergy Clin Immunol, 2001, 107(4):751-762.
  • 8Puxcddu I, Italiani P, Cfiungato P, et al. Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria [J]. Cytokinc, 2013, 61(3):741-743.
  • 9Takahagi S, Mihara S, Iwamoto K, et al. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticariaj L], Allergy, 2010, 65(5): 649-656.
  • 10Kasperska-Zajac A, Sztylc J, Machura E, et al. Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients [J]. Clin Exp Allergy, 2011, 4I( 10): 1386-1391.

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部